Blastoma Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Blastoma stocks.

Blastoma Stocks Recent News

Date Stock Title
May 9 RGLS Regulus Therapeutics GAAP EPS of -$0.29
May 9 CNSP CNS Pharmaceuticals files for $75M mixed shelf offering
May 9 RGLS Regulus Therapeutics Reports First Quarter 2024 Financial Results and Recent Updates
May 9 YMAB Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q1 2024 Earnings Call Transcript
May 9 YMAB Y-mAbs: There's A Ceiling Here Somewhere
May 9 CLDX Wall Street Analysts Believe Celldex (CLDX) Could Rally 67.77%: Here's is How to Trade
May 9 PRLD Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
May 9 YMAB Y-mAbs Therapeutics Inc (YMAB) Q1 2024 Earnings Call Transcript Highlights: Navigating ...
May 9 YMAB Q1 2024 Y-mAbs Therapeutics Inc Earnings Call
May 8 PSTV Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial
May 8 YMAB Y-mAbs Therapeutics, Inc. (YMAB) Q1 2024 Earnings Call Transcript
May 8 YMAB Y-mAbs Therapeutics down 18% as Q1 results disappoint
May 8 CLDX Celldex Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 8 CLRB Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day
May 7 YMAB Y-mAbs Therapeutics Reports Q1 2024 Results: Aligns with EPS Projections, Misses Revenue Estimates
May 7 YMAB Y-mAbs Therapeutics, Inc. (YMAB) Reports Q1 Loss, Misses Revenue Estimates
May 7 YMAB Y-mAbs Therapeutics GAAP EPS of -$0.15 in-line, revenue of $19.93M misses by $2.29M
May 7 YMAB Y-mAbs Reports First Quarter 2024 Financial Results and Recent Corporate Developments
May 7 TCON TRACON to Report First Quarter 2024 Financial Results and Provide Corporate Update on May 14, 2024
May 7 PRLD Prelude Therapeutics GAAP EPS of -$0.42
Blastoma

A blastoma is a type of cancer, more common in children, that is caused by malignancies in precursor cells, often called blasts. Examples are nephroblastoma, medulloblastoma, and retinoblastoma. The suffix -blastoma is used to imply a tumor of primitive, incompletely differentiated (or precursor) cells, e.g., chondroblastoma is composed of cells resembling the precursor of chondrocytes.

Browse All Tags